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Abstract
Review Article
iNtroduCtioN
The oral cavity of humans is coated with a plethora of 
microorganisms.[1] Although most of these are considered as 
“beneficial flora” and have a useful purpose in the body, any 
imbalance can create a widespread havoc to general and oral 
health of the individual.[2] Candida species are normally present as 
commensals in the oral cavity with 30%–50% of a healthy individual 
carrying Candida albicans (C. albicans).[2] However, conditions such 
as chemotherapy and radiotherapy can compromise the immunity 
and self-renewal of epithelial cells leading to disruptions in the 
barriers that normally defend the host against microbial invasion, 
thus predisposing a patient to fungal infections.[3,4] The prevalence 
of clinical fungal infection increased by 24% among head-and-neck 
cancer patients pre- and postradiotherapy/chemotherapy.[5]
Existing evidence on characterizing the oral microbiology 
of healthy individuals[6,7] shows that 40% of the palliative 
patients lose their ability to communicate their oral health 
needs; therefore, they may suffer with treatable oral infections 
for a prolonged period of time.[8] This may contribute to the 
underreporting of oral infections among palliative patients, 
which may result in failure among health professionals to fully 
appreciate the problem. On the other hand, limited knowledge 
about oral conditions and related pathologies among palliative 
patients may continue to remain as a barrier for health-care 
practitioners to devise oral care interventions for this population.
Therefore, this systematic review aimed to synthesize the 
published evidence on the oral microbiology of palliative 
patients, with the following objectives:
• To identify the types of microflora in the oral cavity of 
palliative patients
• To identify the techniques used to investigate the microbiological 
presence in the oral cavity of palliative patients.
Life-limiting diseases such as cancers and its related treatments often compromise normal oral microbial flora and predispose a palliative 
patient to diverse oral infections. Knowledge on microbial flora in the oral cavity of patients with life-limiting diseases is essential to develop 
treatment options for clinical practitioners. This review aimed to systematically synthesize the published evidence on the oral microbiology 
of palliative patients. An integrative review was undertaken with defined search strategy from five databases with manual search through key 
journals and reference list. Studies included were published during the year 2000–2017 focusing on microbiological evidence associated with 
oral conditions among palliative patients. Candida presence was reported in the oral cavity of terminally ill patients in seven of nine articles, 
with Candida albicans being the predominant species. The majority of the included studies used oral swabs as a technique for isolation of the 
organism. This review is first to systematically synthesize the published evidence on the oral microbial flora of palliative patients, taking into 
account the techniques for identification of the microbiota. Larger multicenter studies may help in developing standardized clinical guidelines 
for the oral care of these patients.
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D h ali w al,  et al .: P alli ati v e or al c o n diti o ns
I n di a n J o ur n al of P alli ati v e C ar e ¦ V ol u m e 2 6  ¦ Iss u e 1 ¦ J a n u ar y- M ar c h 2 0 2 0 1 1 1
m e t h o d s
D at a s o ur c e s
S e ar c h str at e g y w as d e vis e d b y t h e r es e ar c h t e a m c o m prisi n g 
of  a  d e nti st  ( J S D), a  p alli ati v e  n ur s e  ( M RV),  a  m e di c al 
d o ct or  ( D R), a n d a h e alt h -c ar e r es e ar c h er  ( ZR). Fi v e el e ctr o ni c 
d at a b as es w er e us e d: S ci e n c e Dir e ct, P u b M e d, G o o gl e S c h ol ar, 
O vi d,  a n d  E B S C O h ost.  M a n u al  s e ar c h  w as  als o  c o n d u ct e d 
t hr o u g h k e y j o ur n als a n d r ef er e n c e list. We li mit e d o ur s e ar c h 
t o arti cl es p u blis h e d fr o m J a n u ar y 2 0 0 0 t o D e c e m b er 2 0 1 7. 
T h e s e ar c h t er ms w er e “ or al c o n diti o n ” O R “ or al dis e as e ” O R 
“ d e nt al dis e as e ” O R “ m o ut h dis e as e ” O R “ m o ut h c o n diti o n ” 
O R m u c ositis O R st o m atitis O R c a n di di asis O R c h eilitis O R 
x er ost o mi a O R “ p eri o d o nt al dis e as e ” O R h alit osis O R t hr us h 
O R “ a n g ul ar c h eilitis ” O R “ d e nt ur e st o m atitis ” O R gi n gi vitis 
O R p eri o d o ntitis O R “ m o ut h ul c er ” O R “ a p ht h o us ul c er ” A N D 
p alli ati v e O R t er mi n all y -ill O R “t er mi n all y ill ” O R “ a d v a n c e d 
dis e as e ” O R “ a d v a n c e d ill n ess ” O R d yi n g O R e n d -of -lif e O R 
h os pi c e O R c a n c er A N D tr e at m e nt O R i nt er v e nti o n O R t h er a p y 
O R m a n a g e m e nt O R “ or al c ar e ” O R “ m o ut h c ar e ” O R “ d e nt al 
m a n a g e m e nt ” A N D “ e n d -of -lif e c ar e. ”
St u d y s el e cti o n
I n cl u si o n  crit eri a  s p e cifi e d  t h at  st u di e s  m u st  b e:  (1)  i n 
f ull  t e xt, ( 2) i n  E n gli s h  l a n g u a g e –  t o e n s ur e  n o  bi a s  i n 
tr a nsl ati o n, ( 3) r es e ar c h arti cl es o nl y –  t o e ns ur e t h e arti cl es 
r etri e v e d  h a d  g o n e  t hr o u g h  p e er-re vi e w e d  pr o c e s s,  ( 4) 
p u blis h e d b et w e e n y e ar 2 0 0 0 a n d 2 0 1 7  –  t o e ns ur e u p -t o-d at e 
r es e ar c h st u di es of t h e t o pi c, ( 5) f o c us e d o n p alli ati v e p ati e nts, 
a n d ( 6) a n al ysis o n mi cr o bi ol o gi c al e vi d e n c e of or al c o n diti o ns.
Fi g ur e  1 ill ustr at es t h e P RI S M A fl o w c h art of st u d y s el e cti o n 
pr o c ess. T h e i niti al c o m bi n e d s e ar c h i d e nti fi e d 2 5, 3 1 1 arti cl es 
fr o m 5 d at a b as es a n d 1 9 arti cl es fr o m ot h er s o ur c es ( m a n u al 
s e ar c hi n g  a n d  t hr o u g h  r ef er e n c es). T h e  titl es  of  t h e  arti cl es 
w er e r e vi e w e d, a n d d u pli c at es w er e r e m o v e d w hi c h r es ult e d i n 
2 5, 2 6 3 b ei n g e x cl u d e d as t h e y di d n ot f o c us o n or al c o n diti o ns 
a m o n g p alli ati v e p ati e nts. T h e a bstr a cts of t h e r e m ai ni n g 6 7 
arti cl es  w er e  r e a d  t o  e ns ur e  t h e  r el e v a n c e  of  t h e  arti cl es  t o 
o ur  st u d y. T his  r es ult e d  i n  2 8  arti cl es  b ei n g  e x cl u d e d. T w o 
r e vi e w ers ( Z R a n d D R) t h e n i n d e p e n d e ntl y r e a d t h e r e m ai ni n g 
3 9  arti cl e s  a n d  c o d e d  t h e m  f or  i n cl u si o n  or  e x cl u si o n. 
F oll o wi n g t h e i n d e p e n d e nt r e vi e w, t h e t w o r e vi e w ers m et t o 
dis c uss pr eli mi n ar y fi n di n gs a n d t o r e a c h a c o ns e ns us o n t h e 
st u di es t o b e i n cl u d e d, a n d t hirt y st u di es w er e e x cl u d e d. T h us, 
f or t h e p ur p os e of a n al ysis, t h er e w er e a t ot al of ni n e arti cl es.
D at a e xtr a cti o n
I n t h e d at a e xtr a cti o n pr o c ess, t h e st u d y d et ails ar e e xtr a ct e d 
i n Ta bl e  1. T his w as d o n e b y t w o r e vi e w ers  ( Z R a n d D R). All 
r e vi e w ers dis c uss e d e a c h arti cl e t o r e a c h c o ns e ns us r e g ar di n g 
t h e st u d y d et ails. T h e f oll o wi n g i nf or m ati o n w as e xtr a ct e d fr o m 
e a c h i n cl u d e d st u d y: a ut h or  (s), y e ar p u blis h e d, titl e, p ur p os e, 
s etti n g, ori gi n of s p e ci m e ns, t e c h ni q u es, a n d mi cr o fl or a.
A s s e s s m e nt of st u d y q u alit y
T h e q u alit y of t h e i d e nti fi e d st u di es w as ass ess e d usi n g J o a n n a 
Bri g gs I nstit ut e criti c al a p pr ais al t o ol  ( a c h e c klist f or a n al yti c al 
cr o s s -s e cti o n al  st u di e s)  w hi c h  c o n si st e d  of  ei g ht  q u e sti o n s 
f o c usi n g  o n  t h e  cl arit y  of  i n cl usi o n  crit eri a,  st u d y  s u bj e cts, 
s etti n g, v ali dit y a n d r eli a bilit y of t h e e x p os ur e a n d o ut c o m e 
m e as ur es, iss u es o n c o nf o u n di n g f a ct ors, a n d a p pr o pri at e n ess 
of st atisti c al a n al ysis us e d. [ 9] E a c h q u esti o n h as a c h oi c e of 
“ y es, ” “ n o, ” “ u n cl e ar, ” or “ n ot a p pli c a bl e ” as a n a ns w er. T h e n, 
a n o v er all a p pr ais al w as m a d e w h et h er t o i n cl u d e or e x cl u d e 
e a c h  st u d y,  or  t o  s e e k  f urt h er  i nf or m ati o n,  wit h  c o m m e nts. 
O nl y t h e arti cl es t h at w er e a gr e e d b y all i n v ol v e d r es e ar c h ers 
w er e i n cl u d e d i n t his s yst e m ati c r e vi e w t o i nf or m t h e fi n di n gs.
D at a a n al y si s
E xtr a ct e d  d at a  fr o m  all  i n cl u d e d  st u di e s  w er e  a n al y z e d 
u si n g  t h e  W hitt e m or e  a n d  K n a fl  pri n ci pl e s  of  i nt e gr ati v e 
r e vi e w wit h f o ur st a g e s: d at a r e d u cti o n, d at a di s pl a y, d at a 
c o m p ari s o n, a n d c o n cl u si o n dr a wi n g a n d v eri fi c ati o n. [ 1 0] At 
d at a  r e d u cti o n  st a g e,  all  ni n e  pri m ar y  s o ur c e s  i n cl u d e d  i n 
t h e  i nt e gr ati v e  r e vi e w  w er e  di vi d e d  i nt o  a  pr e d et er mi n e d 
c o n c e pt u al cl a s si fi c ati o n ali g n e d wit h t h e ai m of t hi s r e vi e w 
w hi c h  i s  mi cr o bi ol o gi c al  pr e s e n c e  i n  t h e  or al  c a vit y  of 
p alli ati v e  p ati e nt s  a n d  it s  i d e nti fi c ati o n  t e c h ni q u e s.  E a c h 
pri m ar y  s o ur c e  w a s  r e d u c e d  t o  a  si n gl e  p a g e  ( a v ail a bl e 
o n r e q u e st fr o m a ut h or s). T hi s h el p e d u s t o s y st e m ati c all y 
R e c or d s i d e ntifi e d t hr o u g h: 
 ci e n c e dir e ct n   
 u e d n   
 o o g e s c h o r n  
 i d n   
 h o st n   
n    
d diti o n  r e c or d s i d e ntifi e d
t hr o u g h ot h er s o ur c e s
i e n u  s e r c hi n g
n d t hr o u g h r ef er e n c e s
n   
R e c or d s r e o e d o n si s
of tit e n d d u i c t e r e o
n    
R e c or d s s cr e e n e d
n   R e c or d s e c u d edn   
 ert o i ni o n n   
 ot o n t r g et e d
  o u ti o n n  
u t e t rti c es
s s e s s e d f or e i gi i it
n   
u t e t rti c e s e c u d e d
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 nt er e nti o n
  r e s e r c h e s n   
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ft er u it  s s e s s e nt
n   
R
Fi g ur e  1:  Pr o c e s s of st u d y s el e cti o n
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Table 1: Summary of studies included
Author (s)/year Title Purpose Setting Origin of 
specimens
Techniques Microflora present
Davies 
et al./2002
Oral yeast carriage 
in patients with 
advanced cancer
To investigate 
oral yeast carriage 
among patients 
with advanced 
cancer
United 
Kingdom
120 advanced 
cancer 
patients
Isolation and identification 
of yeasts from oral swabs
Isolation of yeasts
Using Sabouraud 
dextrose agar and 
CHROMagar™ Candida
Identification of yeasts
Using API 20 C AUX 
yeast identification 
system, species-specific 
PCR and 26S rDNA 
gene sequencing.
Oral yeast carriage present 
in 79 individuals (65.8%). 
Identified isolated 
individual species include:
C. albicans, 46%
C. glabrata, 18%
C. dubliniensis, 5%
Others <5%
Davies 
et al./2008
Oral candidosis 
in community 
based patients with 
advanced cancer
To determine the 
epidemiology, 
etiology, clinical 
features, and 
microbiological 
aspects of oral 
candidosis among 
community-based 
patients
United 
Kingdom
390 advanced 
cancer 
patients
Isolation and identification 
of yeasts from oral swabs
Isolation of yeasts
Using Sabouraud 
dextrose agar and 
CHROMagar™ Candida
Identification of yeasts
Using API 20 C AUX 
yeast identification 
system, species-specific 
PCR and 26S rDNA 
gene sequencing
272 individuals (69.7%) 
had microbiological 
evidence of oral yeast 
carriage
C. albicans found sole in 
patients (n=51) is 26
Non-C. albicans in 
13 patients
Mixed species in 12
Sh/2011 Oral candidiasis 
amongst cancer 
patients at Qods 
hospitals in Sanandaj
To determine the 
occurrence of oral 
candidiasis among 
cancer patients at 
Qods hospitals in 
Sanandaj.
Iran 60 cancer 
patients
Isolation and identification 
of yeasts from oral swabs
Isolation of yeasts
Using Sabouraud dextrose 
agar and CHROMagar
19 Candida species were 
isolated; C. albicans 
outnumbered other species 
and accounted for 73.7% 
episodes of trash
Jayachandran 
et al./2016)
Oral candidiasis 
among cancer 
patients attending a 
tertiary care hospital 
in Chennai, South 
India: An evaluation 
of clinicomycological 
association 
and antifungal 
susceptibility pattern
To determine the 
species of Candida 
isolated from oral 
cavity of patients 
with malignancy
India 180 cancer 
patients on 
chemotherapy 
and/or 
radiotherapy
Two oral swabs taken 
over the lesions, for 
direct Gram staining to 
look for the presence 
of Gram-positive yeast 
cell and pseudohyphae, 
and for inoculating the 
specimen into Sabouraud 
dextrose agar
C. albicans was the 
predominant species 
isolated (94) (58%), 
followed by C. tropicalis 
(34) (20.9%)
Safdar 
et al./2001
Prospective study 
of Candida species 
in patients at a 
comprehensive 
cancer center
To prospectively 
evaluated 
the species 
stratification 
associated with 
heavy colonization 
and systemic 
infection in patients 
at Memorial Sloan 
Kettering Cancer 
Center in New York
United 
States of 
America
223 patients 
with cancer 
and AIDS
A germ tube test was 
performed for presumptive 
identification of C. albicans. 
Organisms that failed to 
form a germ tube were 
further tested by the 
auxanographic plate method
Five to ten colonies were 
obtained from the primary 
culture and transported on 
Trypticase agar slants
C. albicans was the 
predominant species 
accounting for 235/349 
Candida isolates (67.3%)
Among 114 non-albicans 
Candida spp.
C. glabrata (45.6%)
C. tropicalis (18.4%)
C. parapsilosis (16.6%)
C. krusei (9.6%)
Suhail Lone 
et al./2014
Oral Candida 
colonization and 
infection in cancer 
patients and 
their antifungal 
susceptibility in a 
tertiary care hospital
To investigate 
the epidemiology 
of oral yeast 
colonization and 
infection among 
cancer patients
India 150 cancer 
patients and 
150 healthy 
controls
Oral swabs (from tongue, 
buccal mucosa, and 
labial sulcus) taken from 
all the participants for 
yeast culture by directly 
inoculating on HiCrome 
Candida differential agar
Among the cancer group, 
total colonization was 
prevalent in 50% and oral 
candidiasis in 30% of all 
cancer patients
C. albicans was the most 
common species (74.39%) 
causing colonization and 
candidiasis with 100% 
susceptibility to the two 
azoles
Contd...
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Table 1: Contd...
Author (s)/year Title Purpose Setting Origin of 
specimens
Techniques Microflora present
Alt-Epping 
et al./2012
Symptoms of the 
oral cavity and their 
association with local 
microbiological and 
clinical findings: 
A prospective survey 
in palliative care
To assess the 
subjective 
symptom burden 
and the prevalence 
of clinical and 
microbiological 
oral findings
Germany 101 cancer 
patients
Oral swab taken from 
buccal mucosa, the 
palatal ring, and tongue 
for culture, followed 
by a mouth wash for 
quantitative HSV DNA 
testing, using PCR 
technique
Yeasts were found 
in mouth swabs of 
70 patients, and HSV DNA 
was detected in 19 patients
Presence of Candida 
species was 88% among 
the study participants
Davies 
et al./2006
Oral candidosis 
in patients with 
advanced cancer
To determine the 
epidemiology, 
etiology, clinical 
features, and 
microbiological 
aspects of oral 
candidosis in a 
cohort of patients 
receiving specialist 
palliative care
United 
Kingdom
120 advanced 
cancer 
patients
Isolation and identification 
of yeasts from oral rinses 
and oral swabs
Isolation
Using Sabouraud 
dextrose agar and 
CHROMagar Candida
Identification
Using API 20 C AUX 
yeast identification 
system, PCR (nested), 
and DNA sequencing
79 individuals (66%) had 
microbiological evidence 
of oral yeast carriage
36 individuals (30%) had 
combined clinical and 
microbiological evidence 
of oral candidosis
C. albicans was the 
predominant organism 
isolated from the oral 
swabs of patients with oral 
candidosis
Astvad et al., 
2015
OPC in palliative 
care patients in 
Denmark
To evaluate the 
clinical and 
microbiological 
incidence of yeast 
carriage/OPC
Denmark 54 terminally 
ill patients
Paired samples from the 
buccal mucosa and the 
surface of the tongue 
were taken. The sampling 
included one sterile 
cotton swab smeared on 
a glass slide, fixated with 
methanol, followed by a 
sterile charcoal swab in 
Stuart Transport Medium
Yeast carriage rate 
was 83%. C. albicans 
accounted for half of the 
isolates cultured
C. albicans: Candida albicans, C. glabrata: Candida glabrata, C. dubliniensis: Candida dubliniensis, HSV: Herpes simplex virus, OPC: Oropharyngeal 
candidiasis, PCR: Polymerase chain reaction
compare primary sources on specific issues, variables, and 
sample characteristics. It also allowed us to organize data 
into a manageable framework.
At Stage 2 – data display, the single-page data from the nine 
included studies are then extracted and displayed in Table 1. 
This helped us to visualize the patterns and relationships 
between and within primary data sources.
At Stage 3 – data comparison, we used constant comparison 
as a method of an iterative process of examining data to 
identify themes that had similar patterns and relations.
Finally, at Stage 4 – conclusion and verification, we verified 
patterns using primary data and identified any similarities, 
differences, and any spurious findings. These were dealt with 
in order to ensure that valuable information was not lost. Five 
meetings were held in order to identify and reach a consensus 
on the final themes.
results
Characteristics of study
Overall, nine articles were found eligible and included in 
this review. The included study settings involved patients 
of advanced cancer conditions or palliative patients from 
five European, three Asian, and one American country. The 
total number of each study participants ranged from 54 to 
390. The microbiological evidence of oral conditions among 
palliative patients of the nine eligible studies is summarized 
in Table 1.
Common oral microorganisms present in palliative patients
Of nine studies, seven specifically reported Candida presence 
in the oral cavity of palliative patients.[3,11-16] Two studies 
reported the presence of yeast carriage.[17,18] C. albicans was the 
predominant species with at least 50% of the total mycological 
infection reported in seven of nine studies [Table 1]. Other 
species of Candida reported were Candida glabrata, Candida 
dubliniensis, Candida tropicalis, Candida parapsilosis, and 
Candida krusei.
Predisposing factors for oral microbial pathology among 
palliative patient
Two studies reported dentures, xerostomia, and oral hygiene 
as predisposing factors for oral microbial pathology among 
palliative patients.[11,17] Another study reported antibiotic 
and corticosteroid usage as predisposing factors for Candida 
species infections.[15] Another prospective study considered 
clinical findings and laboratory findings to develop appropriate 
treatment strategies.[18]
Dhaliwal, et al.: Palliative oral conditions
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Association between oral symptoms and oral microbial flora
Only three studies reported a significant association between 
the presence of oral symptoms and the oral microbial flora, 
Jayachandran et al. found a significant association between 
dry mouth symptom and presence of Candida species.[3] 
Davies reported that oral yeast carriage and denture wearing 
were significantly associated (P < 0.006). Similarly, there was 
an association between oral yeast carriage and low salivary 
flow rate (P < 0.009).[11] Finally, a significant association 
was reported between prior treatment with triazole and 
isolation of fluconazole-resistant C. albicans (P < 0.005), 
but this relationship was not observed in C. glabrata isolates 
(P = 0.4).[13] The other six studies reported only the mean and 
percentage of various Candida species.
Techniques used for identification of microbiological presence
Of the nine studies, eight studies used oral swabs to identify 
the microbiological presence except one,[13] where a germ tube 
test was used for presumptive identification of C. albicans. 
In five studies, Sabouraud dextrose agar and/or CHROMagar 
were used for isolation of microbes,[3,11,12,15,17] one study used 
Trypticase agar slants,[13] another study used HiCrome Candida 
differential agar,[14] and two studies did not specify the type 
of agar used.[16,18]
Two studies adapted antifungal susceptibility test that used 
minimum inhibition concentration of various antifungal agents 
such as azoles, nystatin, and amphotericin against different 
isolates of Candida species.[12,16]
Another two studies performed Clinical and Laboratory 
Standards Institute-guided microbroth dilution method to 
detect antifungal susceptibility.[3,14] Another study used the 
National Committee for Clinical Laboratory Standards 
guidelines to identify antifungal susceptibility.[13]
disCussioN
Our systematic review found Candida as the most common 
microflora in the oral cavity of palliative patients, with 
C. albicans being the predominant species. This finding 
is worrying because although C. albicans is often present 
as commensal in the oral cavity, their transition as an 
opportunistic pathogen is made possible when the host 
defense is compromised,[19] for example, patients undergoing 
chemotherapy and/or radiotherapy targeting carcinomas and 
sarcomas.[19] This is evident as oral candidiasis is common in 
head-and-neck cancer patients,[19] with 70%–75% Candida 
carriage in patients taking chemotherapy and/or radiotherapy.[20] 
A study reported that chemotherapy and/or radiotherapy causes 
mucositis and changes in saliva consistency. Xerostomia or 
thick saliva makes the oral environment conducive for fungal 
colonization.[21]
Oral candidiasis is also a common side effect of cancer 
treatments which harm the body’s mucous membranes and 
further weaken the immune system, making it more difficult 
for the body to fight off the Candida infection.[16,22] Studies 
have suggested the use of antifungal medications during cancer 
treatment to prevent an infection.[16,22] In palliative conditions, 
diverse form of antifungal medications, such as mouthwashes, 
gels, ointments, capsules, or given as an infusion, and can help 
to have an effect on a limited local region (topical), on the 
entire body (systemic) or with a combined effect. However, 
no evidence is available whether these antifungal medications 
can help reduce other oral candidiasis symptoms such as pain 
or difficulty swallowing.
There are various techniques available for the isolation of 
Candida within the oral cavity such as the use of smear, an 
imprint culture, collection of whole saliva, concentrated oral 
rinse, and mucosal biopsy,[23] and the majority of our included 
studies only used oral swabs for isolation. It is a relatively 
simple method of detecting growth of microflora, site specific, 
and can obtain semi-quantitative estimation of Candida, and 
this technique is difficult to standardize.[23] Since Candida is 
the resident microflora within the oral cavity, a more reliable 
and appropriate isolation methods are required to ascertain its 
presence along with their quantity.
CoNClusioN
To our knowledge, this study is the first systematic review 
taking into account the techniques to identify the oral 
microflora among palliative patients. It is hoped that the 
information generated from this review will lead to a better 
understanding of oral conditions among palliative patients in 
order to direct the treatment options and enhance the quality 
of care for these terminally ill patients. Future studies with 
multicenter approach may help to develop standardized clinical 
guidelines for oral care of palliative patients.
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